ADVFN - ニュース

S&P 500

5,352.96

-0.02%

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/07	17 : 48	GlobeNewswire Inc.	Form 8.5 (EPT/RI) - Capital & Regional Plc
2024/06/07	17 : 48	Alliance News	IN BRIEF: Diversified Energy completes "unique" purchase from Oaktree	LSE:DEC	Diversified Energy Company Plc
2024/06/07	17 : 46	PR Newswire (US)	EASL Wrap-up Session Highlighted Late-Breaking Clinical Data of First-in-class HBV-specific TCR T Cell Therapy (SCG101) Showing Improved Overall Survival in HBV-related Hepatocellular Carcinoma
2024/06/07	17 : 45	Alliance News	LONDON BROKER RATINGS: Bryan Garnier raises ITM Power to 'neutral'
2024/06/07	17 : 43	GlobeNewswire Inc.	Form 8.5 (EPT/RI) - musicMagpie Plc
2024/06/07	17 : 43	Alliance News	IN BRIEF: Helios Underwriting CEO Martin Reith steps down	LSE:HUW	Helios Underwriting Plc
2024/06/07	17 : 43	PR Newswire (US)	Fibocom Launches a Series of On-device AI Solutions for Compute-intensive Applications powered by Qualcomm-based Platforms at Computex 2024
2024/06/07	17 : 40	GlobeNewswire Inc.	Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
2024/06/07	17 : 38	GlobeNewswire Inc.	Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
2024/06/07	17 : 38	GlobeNewswire Inc.	Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
2024/06/07	17 : 38	GlobeNewswire Inc.	Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis	TG:22Z	Zealand Pharma AS
2024/06/07	17 : 37	GlobeNewswire Inc.	Form 8.5 (EPT/RI) - FireAngel Safety Technology Group Plc
2024/06/07	17 : 36	Business Wire	Global ABS 2024: Day 3 Recap
2024/06/07	17 : 31	Alliance News	Worldwide Healthcare Trust beats benchmark but lowers dividend	LSE:WWH	Worldwide Healthcare Trust Plc
2024/06/07	17 : 30	GlobeNewswire Inc.	Form 8.5 (EPT/RI) - NewRiver REIT Plc
2024/06/07	17 : 30	GlobeNewswire Inc.	Renewi joins FTSE 250	LSE:RWI	Renewi Plc
2024/06/07	17 : 30	GlobeNewswire Inc.	Renewi joins FTSE 250	TG:1K5A	Renewi Plc
2024/06/07	17 : 30	GlobeNewswire Inc.	Renewi joins FTSE 250	EU:RWI	Renewi Plc
2024/06/07	17 : 30	GlobeNewswire Inc.	Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:TPST	Tempest Therpeutics Inc
2024/06/07	17 : 30	GlobeNewswire Inc.	Renewi joins FTSE 250	LSE:RWI	Renewi Plc
2024/06/07	17 : 30	GlobeNewswire Inc.	Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
2024/06/07	17 : 30	Business Wire	Leroy Merlin Enriches the Customer Experience With Hanshow Digital Solutions
2024/06/07	17 : 30	GlobeNewswire Inc.	The Japanese company COLOPL takes a strategic stake of 12.5% in the capital of CBI for 12.5 million euros and entrusts it with exclusive rights to operate the Web 3.0 game Brilliantcrypto
2024/06/07	17 : 30	Business Wire	Leroy Merlin verbessert das Kundenerlebnis mit digitalen Lösungen von Hanshow
2024/06/07	17 : 30	GlobeNewswire Inc.	Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
2024/06/07	17 : 30	Business Wire	ルロイ・メルランの顧客体験向上にHanshowのデジタルソリューションを導入
2024/06/07	17 : 30	PR Newswire (US)	FluentEdge Marketing Agency Launches to Revolutionize Marketing in the Addiction Treatment Field
2024/06/07	17 : 28	GlobeNewswire Inc.	Flash News: OKX Wallet Now Integrated with Me3 DeFi Platform
2024/06/07	17 : 27	GlobeNewswire Inc.	Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
2024/06/07	17 : 27	Business Wire	Nuclera Awarded £1.14M Innovate UK Funding for Development of eProtein Discovery